secwatch.observer — SEC 8-K summary
======================================

Issuer:     DBV Technologies S.A. (DBVT)
CIK:        0001613780
Form:       8-K
Filed at:   2023-05-04T23:59:59+00:00
Accession:  0001193125-23-136025
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DBV Technologies Q1 net loss widens to $20.5M; cash drops to $192.3M
--------------------------------------------------------------------

- Cash and equivalents $192.3M as of March 31, 2023, down from $209.2M at Dec 31, 2022.
- Net loss of $20.5M for Q1 2023 vs $16.7M loss in Q1 2022; loss per share $0.22.
- R&D expenses rose 31% to $16.0M, driven by initiation of VITESSE trial in March 2023.
- Cash used in operations $20.8M vs $1.5M in Q1 2022; prior year included $20.9M French R&D tax credit receipt.
- Total operating expenses $23.3M, up 21% from $19.3M in Q1 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1613780/000119312523136025/0001193125-23-136025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1613780/000119312523136025/d298404d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-136025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer